TozinameranTransplant rejection and thrombotic microangiopathy: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1929卷 / 1期

关键词：

D O I：

10.1007/s40278-022-26246-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：622 / 622

相关论文

共 50 条

[21] AntineoplasticsLack of efficacy and thrombotic microangiopathy: case report
Reactions Weekly, 2023, 1975 (1) : 43 - 43
[22] Interferon-βThrombotic microangiopathy: case report
Reactions Weekly, 2019, 1778 (1) : 256 - 256
[23] Baricitinib/tocilizumabAcute thrombotic microangiopathy: case report
Reactions Weekly, 2020, 1835 (1) : 65 - 65
[24] AntineoplasticsChronic thrombotic microangiopathy in kidney: case report
Reactions Weekly, 2020, 1799 (1) : 65 - 65
[25] TacrolimusDe novo thrombotic microangiopathy: case report
Reactions Weekly, 2021, 1875 (1) : 314 - 314
[26] Gemcitabine/paclitaxelPancytopenia and thrombotic microangiopathy : case report
Reactions Weekly, 2023, 1950 (1) : 204 - 204
[27] Interferon-αThrombotic microangiopathy: case report
Reactions Weekly, 1999, 778 (1) : 10 - 10
[28] BortezomibRenal and pulmonary thrombotic microangiopathy: case report
Reactions Weekly, 2019, 1775 (1) : 102 - 102
[29] BevacizumabProteinuria and renal thrombotic microangiopathy: case report
Reactions Weekly, 2024, 2037 (1) : 92 - 92
[30] BevacizumabIgA vasculitis and thrombotic microangiopathy: case report
Reactions Weekly, 2019, 1784 (1) : 64 - 64

← 1 2 3 4 5 →